Selected Grants
A Phase 3 Multi-center Randomized Open-Label Study of Carbavance (Meropenem/PRX7009) Versus Best Available Therapy in Subjects with Selected Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
Clinical TrialPrincipal Investigator · Awarded by Rempex Pharmaceuticals · 2014 - 2017Rempex 506-NH - Retro Chart Review
ResearchPrincipal Investigator · Awarded by Rempex Pharmaceuticals · 2014 - 2015External Relationships
- Huff Powell Bailey (Law firm)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.